Insider Profile
Kim, Yunji
1
Companies Filed At
18
Open-Market Buys (2yr)
$23K
Buy Value (2yr, open-market)
Jun 25, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
Date Company Role Nature Dir. Shares Price Value Score
Jun 25, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 6,000 $0.92 $6K 55
Jun 25, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 3,000 $0.90 $3K 55
Jun 25, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,000 $0.91 $910 55
Jun 25, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 500 $0.99 $495 55
Jun 23, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 7,000 $0.98 $7K 55
Jun 23, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 20 $0.90 $18 55
Jun 23, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,000 $0.96 $960 55
Jun 19, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,000 $0.95 $950 55
Jun 17, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 500 $0.98 $490 55
Jun 17, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 500 $0.97 $485 55
Jun 15, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,500 $0.93 $1K 55
Jun 12, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 20 $0.94 $19 55
Jun 10, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 20 $0.98 $20 55
Jun 10, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 20 $0.94 $19 55
Jun 09, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 20 $0.95 $19 55
Jun 08, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 100 $0.95 $95 55
Jun 05, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,500 $0.85 $1K 55
Jun 05, 2026 $EBM
Eastwood Bio-Medical Canada Inc.
Open Market Buy 1,000 $0.85 $850 55
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.